Yan Moore

Yan Moore

Chief Tech/Sci/R&D Officer at OMEGA THERAPEUTICS, INC.

Net worth: - $ as of 30/04/2024

58 year
Health Technology
Consumer Services
Retail Trade

Network origin in Yan Moore first degree

EntityEntity typeIndustry
Public Company Biotechnology 19
Subsidiary Biotechnology 11
Extinct Biotechnology 8
4
Private Company Pharmaceuticals: Major 4

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Yan Moore via their personal network

CompanySectorRelated peopleMain position
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Michelle Werner

Howard Mayer

Elliott Levy

Joshua Reed

Kevin McManus

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Human Resources Officer

Investment Managers

John Mendlein

Noubar Afeyan

Christian Schade

Michelle Werner

Private Equity Analyst

Chief Executive Officer

Private Equity Investor

Private Equity Investor

NOVARTIS AG Pharmaceuticals: Major

Sotirios G. Stergiopoulos

Roger Sawhney

Ling Zeng

Corporate Officer/Principal

Corporate Officer/Principal

General Counsel

Massachusetts Institute of Technology College/University

Noubar Afeyan

Anna Protopapas

Richard Young

Director/Board Member

Graduate Degree

Corporate Officer/Principal

Drugstore Chains

Mary Szela

Mahesh Karande

Thomas McCauley

Director/Board Member

Chief Executive Officer

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Nicholas Ventresca

Howard Mayer

Ronald Knickerbocker

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Harvard Medical School College/University

Frank G. Haluska

Roger Sawhney

Corporate Officer/Principal

Doctorate Degree

Yale University College/University

Harvey J. Berger

Richard Young

Corporate Officer/Principal

Doctorate Degree

Medical Specialties

Thomas DesRosier

Ronald Knickerbocker

General Counsel

Corporate Officer/Principal

Pharmaceuticals: Major

John Mendlein

Noubar Afeyan

Chief Executive Officer

Founder

DICERNA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Anna Protopapas

Ling Zeng

Director/Board Member

General Counsel

Stanford Graduate School of Business College/University

Anna Protopapas

Robert Whelan

Masters Business Admin

Masters Business Admin

College/University

Thomas McCauley

Kevin McManus

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

John Mendlein

Noubar Afeyan

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

John Mendlein

Paris Panayiotopoulos

Director/Board Member

Director/Board Member

AXCA HEALPAR Biotechnology

John Mendlein

Noubar Afeyan

Director/Board Member

Founder

Pharmaceuticals: Major

Howard Mayer

Paris Panayiotopoulos

Chief Tech/Sci/R&D Officer

President

EDITAS MEDICINE, INC. Biotechnology

John Mendlein

Elliott Levy

Director/Board Member

Director/Board Member

MODERNA, INC. Biotechnology

John Mendlein

Noubar Afeyan

Director/Board Member

Founder

Miscellaneous Commercial Services

John Mendlein

Noubar Afeyan

Director/Board Member

Founder

Biotechnology

John Mendlein

Noubar Afeyan

Director/Board Member

Founder

ALIMERA SCIENCES, INC. Pharmaceuticals: Major

Mary Szela

Roger Sawhney

Director/Board Member

Director/Board Member

McGill University College/University

Noubar Afeyan

Karla MacDonald

Undergraduate Degree

Undergraduate Degree

University of Pennsylvania College/University

Michelle Werner

Howard Mayer

Undergraduate Degree

Undergraduate Degree

Yale School of Medicine College/University

Harvey J. Berger

Elliott Levy

Corporate Officer/Principal

Doctorate Degree

The Hebrew University of Jerusalem College/University

Avraham Hochberg

Ruth Alon

Doctorate Degree

Undergraduate Degree

IPSEN Pharmaceuticals: Major

Howard Mayer

Sotirios G. Stergiopoulos

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Howard Mayer

Thomas McCauley

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Princeton University College/University

Christian Schade

Anna Protopapas

Undergraduate Degree

Undergraduate Degree

College/University

Isaac Kohlberg

Frank G. Haluska

Chief Tech/Sci/R&D Officer

Undergraduate Degree

Biotechnology

Isaac Kohlberg

Frank G. Haluska

Director/Board Member

Director/Board Member

Biotechnology

Noubar Afeyan

Michelle Werner

Chairman

Chief Executive Officer

College/University

Efrat Makov

Isaac Kohlberg

Undergraduate Degree

Graduate Degree

SERES THERAPEUTICS, INC. Biotechnology

Noubar Afeyan

Thomas DesRosier

Founder

General Counsel

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Timothy J. Maines

Sivakesava Sakhamuri

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

The Wharton School of the University of Pennsylvania College/University

Christian Schade

Mahesh Karande

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

Christian Schade

Timothy J. Maines

Director of Finance/CFO

Corporate Officer/Principal

JPMORGAN CHASE & CO. Major Banks

Christian Schade

Joshua Reed

Corporate Officer/Principal

Corporate Officer/Principal

ALPHA TAU MEDICAL LTD. Medical Specialties

Ruth Alon

Director/Board Member

PEPGEN INC. Biotechnology

Howard Mayer

Director/Board Member

GENOCEA BIOSCIENCES, INC. Biotechnology

Howard Mayer

Director/Board Member

Pharmaceuticals: Major

Paris Panayiotopoulos

Corporate Officer/Principal

Cranfield School of Management College/University

Paris Panayiotopoulos

Graduate Degree

Biotechnology

Ruth Alon

Director/Board Member

European Pharmaceutical Market Research Association

Paris Panayiotopoulos

Director/Board Member

Miscellaneous Commercial Services

Paris Panayiotopoulos

Corporate Officer/Principal

Statistics

International

United States 41
Israel 4
Switzerland 3
United Kingdom 3
Canada 2

Sectoral

Health Technology 27
Consumer Services 14
Commercial Services 6
Finance 4
Retail Trade 2

Operational

Director/Board Member 209
Corporate Officer/Principal 102
Founder 60
Independent Dir/Board Member 58
Chairman 53
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW